Investigating bile acids and genetic mutations in pregnancy-related liver disorder in Indian women
Official title: Bile Acids Metabolism and Genetic Mutation Profile in the Etiopathogenesis of Intrahepatic Cholestasis of Pregnancy in Indian Population- A Prospective Study
Run by Post Graduate Institute of Medical Education and Research, Chandigarh · NCT05691036 · Data updated 2026-11-12
This study is testing the connection between bile acids and genetic changes in Indian women with a pregnancy-related liver condition called Intrahepatic Cholestasis of Pregnancy to see how it affects them and their babies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years to 45 Years |
| Sex | Women only |
| Enrollment | 150 (estimated) |
| Sponsor | Post Graduate Institute of Medical Education and Research, Chandigarh Academic / other |
| Locations | 1 site (Chandigarh, Chandigarh) |
| Status | Recruiting |
| Started | December 8, 2022 |
| Main results expected | July 2026 |
| Study ends | July 2026 |
| Registry record updated | May 18, 2026 |
| Trial ID | NCT05691036 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women over 21 years old with consistent itching and elevated liver enzymes or bile acids.
✕Probably not a fit
Patients with viral liver diseases or primary dermatologic conditions causing pruritus will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on Intrahepatic Cholestasis of Pregnancy (ICP), a condition characterized by severe itching and elevated bile acids during pregnancy. It aims to analyze the metabolic profile of bile acids and the genetic mutation profile in affected women from the Indian population. The study will include women over 21 years old who experience consistent pruritus and elevated liver enzymes or bile acids. Participants will be monitored until delivery to assess maternal and perinatal outcomes.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of ICP, potentially improving outcomes for mothers and their babies.
How similar studies have gone: While there have been studies on ICP, this specific focus on bile acids and genetic mutations in the Indian population is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria - * Age \> 21 years with consistent pruritus * Characterized by consistent pruritus associated with elevated levels of serum transaminases (ALT \> 40 U/L or AST \> 37 U/L) or raised total serum bile acids (≥ 10 µmol/L) * Able to understand and comply with the requirements of the study and voluntarily agrees to participate in the study by giving written informed consent before any study-related activity is performed * Voluntary informed consent to participate until their delivery and also willing to be followed until their delivery * Agrees to provide information on perinatal and maternal outcomes at or after delivery Exclusion Criteria: * Viral and Infectious diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV) related liver disease, Epstein Barr virus (EBV), Cytomegalovirus (CMV), human immunodeficiency virus (HIV) infection) hepatitis C virus (HBV), hepatitis E virus (HEV) * Primary dermatologic diseases associated with pruritus * Metabolic diseases (including alcohol abuse) * Other causes of cholestasis (i.e., primary biliary cholangitis (PBC); primary sclerosing cholangitis (PSC) * Autoimmune liver disease * Obstructive biliary diseases * Cholestatic drug-induced liver injury * Clinical severe conditions that may affect outcomes include heart failure, renal failure, primary cardiopulmonary diseases * Twins and triplet pregnancy
Where it's running
-
Dr. Madhumita Premkumar
Chandigarh, Chandigarh, India Recruiting
Study contacts
- Principal investigator: Madhumita Premkumar — PGIMER, Chandigarh
- Study coordinator: Dr Madhumita Premkumar, DM
- Email: drmadhumitap@gmail.com
- Phone: 7087003409
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Telecare psychosocial and cognitive program for kids with limb-girdle muscular dystrophy
A telecare-based group program is tested to see if it helps 7- to 17-year-olds with limb-girdle muscular dystrophy improve quality of life and social skills.
-
See if an interprofessional health needs assessment improves quality of life for older adults living at home
This randomized trial tests whether an interprofessional health needs assessment helps people 65 and older living at home have better health-related quality of life and use health services more appropriately.
-
Health Ahead: Comparing AI vs. Humans for Preventive Health Screening
This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.
-
Mobile-based telemedicine to improve quality of life for chronic heart failure patients
We’re testing whether a mobile phone–based program that sends reminders, education, and follow-up can improve quality of life for adults with chronic heart failure in Ethiopia.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
Intergenerational Mentoring to Reduce Loneliness and Improve Well-Being
This project tests intergenerational mentoring between seniors 60+ and youths aged 12–21 in Hamburg to see if it reduces loneliness and improves mental well-being and quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.